Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $7.3 Million - $8.28 Million
-263,700 Reduced 31.43%
575,200 $16.6 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $1.13 Million - $1.32 Million
44,600 Added 5.62%
838,900 $23.5 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $6.09 Million - $6.99 Million
-235,100 Reduced 22.84%
794,300 $22 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $7.22 Million - $9.38 Million
276,500 Added 36.72%
1,029,400 $29.6 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $11.7 Million - $13.7 Million
365,300 Added 94.25%
752,900 $25 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $12 Million - $13.9 Million
332,400 Added 602.17%
387,600 $14.2 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $677,508 - $882,016
17,200 Added 45.26%
55,200 $2.25 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $588,675 - $768,450
14,100 Added 59.0%
38,000 $1.95 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.05 Million - $1.28 Million
23,900 New
23,900 $1.05 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $1.54 Million - $1.74 Million
-46,700 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $792,756 - $1.03 Million
24,400 Added 109.42%
46,700 $1.68 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $835,747 - $938,352
-22,600 Reduced 50.33%
22,300 $966,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $1.68 Million - $1.85 Million
44,900 New
44,900 $1.91 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.